Objectives In 2003, a cluster of renal cell carcinoma (RCC) cases was reported among men working at a French chemical plant using a proprietary process to produce vitamin A. The 10 index cases yielded a standardised incidence ratio of 13.1 for 1994-2002. Nine of these 10 cases were diagnosed by a plant-specific abdominal ultrasonography screening programme that targeted exposure to an intermediate chemical, 4-chloro-1,1-dimethoxy-3-methyl-2-butene, commonly named 'chloracetal C5', suspected as the cause by some experts. Epidemiological investigations sought to examine the relations between occupational exposures and RCC. Methods A retrospective cohort mortality study and a nested case-control study were conducted. The cohort study included all workers who had been employed at the plant for at least 6 months between 1960 and 2003. The case-control study included an extensive search within the region for other kidney cancer cases among the cohort members. Industrial hygienists assessed occupational exposure.
INTRODUCTION
In January 2003, the French Ministries of Labour and of Health asked the French Institute for Public Health Surveillance (InVS) to investigate a possible cluster of kidney cancer cases in a chemical plant located in the Auvergne region of France. The plant has specialised in the production of vitamin A, vitamin E and methionine for animal feed since the early 1950s. Nearly 600 different chemicals have been used or synthesised there. In 2003, the plant employed about 700 workers. Ten cases of kidney cancer had been reported, all involving renal cell carcinoma (RCC), including seven clear-cell and three papillary cases. 1 They had been diagnosed in men who had been employed at the plant between 1994 and 2002. Nine of these 10 index cases were diagnosed after their enrolment in an abdominal ultrasound screening programme conducted by the plant. The programme was set up in 1986 to detect possible hepatic tumours among workers exposed to vinyl chloride, either in a previous job in a plant producing the polyvinyl chloride polymer, or in the present plant-that is, workers in the A or E vitamin synthesis workshops. In 1992, the screening programme was extended to workers exposed to an intermediate chemical, 4 -chloro-1,1-dimethoxy-3-methyl-2-butene, commonly named 'chloracetal C5' (C 7 H 13 ClO 2 , CAS number:105737-73-3) after in vitro observations of a mutagenic effect in the early What this paper adds ▸ Some experts suspected that 4-chloro-1,1-dimethoxy-3-methyl-2-butene, commonly named 'chloracetal C5', an intermediate chemical in the synthesis of vitamin A, was the origin of a cluster of renal cell carcinoma (RCC) cases observed in a plant manufacturing vitamin A and vitamin E for animal feed supplements in France. ▸ Several factors suggested that a successful epidemiological investigation could be conducted: the large number of RCC cases initially reported, the significantly elevated standardised incidence ratio, the single type of disease, the potential availability of subjects' work histories, and the in vitro genotoxicity of the chloracetal C5. ▸ In a nested case-control study, RCC risk increased significantly with cumulative exposure to chloracetal C5 but this doseresponse relation was substantially attenuated after adjustment for screening by abdominal ultrasonography. ▸ Despite the difficulty of reaching a definite conclusion about the causal role of chloracetal C5, the observation of a dose-response relation and the positive in vivo genotoxic tests provide support for this hypothesis. ▸ We recommend that plants keep identifying data and work histories of their employees in computerised files to facilitate future epidemiological surveillance and cluster analyses.
1990s. In 2000, this programme was extended to all employees who volunteered to undergo the screening. Chloracetal C5, a chlorinated aldehyde, is produced during the synthesis of vitamin A in a proprietary industrial procedure (henceforth referred to as Navas) performed at the plant since 1981. Some experts suspected that it was the cause of the RCC cases observed. Little is known about the toxicity of chloracetal C5. During the industrial start-up of the Navas procedure in the early 1980s-that is, 1980-1984-numerous technical problems arose with the accumulation of chloracetal C5 in solid form which had required the intervention of workers and entailed skin or respiratory contact. The known risk factors for RCC are cigarette smoking, hypertension and obesity 2 but the potential role of occupational factors in its occurrence has been the object of increasing study in recent decades. Studies have explored the effect of occupational exposure to asbestos, 3 4 artificial mineral fibres, 5 polycyclic aromatic hydrocarbons (PAHs), 6 7 solvents, in particular trichloroethylene, [8] [9] [10] and vinyl chloride. 11 Exposure to heavy metals has been shown to be associated with RCC risk. [11] [12] [13] [14] [15] [16] But no epidemiological study had yet been conducted on chloracetal C5 since this intermediate chemical is, to the best of our knowledge, produced only during the Navas procedure and thus only at this plant.
In a preliminary stage, a standardised incidence ratio (SIR) for the 10 index cases was calculated among the men working at the plant between 1994 and 2002. The estimated SIR of 13.1 confirmed an excess of kidney cancers. 1 Nonetheless, this could partially be explained by the early diagnosis due to the abdominal ultrasound screening. Indeed, screening can lead to overdiagnosis, which results from the detection of cancers that are either not progressive or very slow growing. 17 Thus, the number of RCC cases initially identified might have been increased by early diagnosis after screening. In view of the scarcity of available knowledge about the renal toxicity of chloracetal C5 and the presence of several known hazardous substances in the plant, we investigated this cluster by conducting a retrospective cohort mortality study aimed at exploring the general mortality pattern, in particular, cancer mortality, and a nested case-control study focusing on RCC and occupational exposures, especially to chloracetal C5. The protocols of the cohort and of the case-control studies were approved by the French authority in charge of privacy and personal data protection.
The plant, for its part, commissioned a toxicology laboratory to conduct further genotoxic studies on chloracetal C5.
METHODS

Cohort study
The cohort consisted of all workers employed at the plant for at least 6 months (not necessarily consecutively) between 1 January 1960 and 31 December 2003. The data were abstracted from administrative records. Each subject's job history within the plant was reconstructed from January 1960 or hiring date, whichever came later, until he or she left the plant or December 2001, whichever came first. Job assignments were abstracted from pay sheets.
This cohort was followed up for mortality between 1 January 1968 (when the French cause-of-death registry was established) and 31 December 2006. The vital status of the subjects was sought in the French national death registry. Causes of death were ascertained through linkage with the cause-of-death registry. Diagnosis of the 10 index cases had histologically been confirmed.
Case-control study
1 Among the 12 additional cases, diagnosis was based on death certificate in three cases, Computed tomography (CT) results in one case and histological confirmation for the remaining seven cases. Before establishing inclusion criteria, the feasibility of reaching and interviewing the subjects was examined. This test showed that reaching the family members and colleagues of the subjects deceased a long time ago or who were very old at the time of the interview would be extremely difficult. Thus, for this feasibility reason, we decided that the cases included in this study were RCCs observed between 1 January 1980 and 31 December 2003 in cohort members born after 1925. Therefore, four out of the 12 additional cases were not included. The controls were chosen with the incidence density sampling method. 18 19 Five controls were sampled within each risk set with matching for sex and year of birth (within 2.5 years). The number of five controls per case was determined by a statistical power analysis. A list of five additional alternative controls was also established in case some of the primarily selected control subjects refused to participate or could not be reached.
Data collection
Four trained interviewers questioned subjects at the plant or at their homes in 2005 and 2006. Proxy interviews were conducted with family members and/or colleagues of subjects who had died. Standardised questionnaires were used to collect information: subjects were asked about potential risk factors of RCC, that is, smoking habits, medical history, especially hypertension, diabetes, and kidney disease, and about their height and weight. Specific occupational questionnaires were designed to obtain, for each job held at the plant and elsewhere, a description of the tasks performed, departments of assignment, industrial phase of assignment for production workers, time spent on the main tasks, and direct contact with some specific nuisances.
Exposure assessment
Industrial hygienists, blinded to the case-control status of each subject, assessed occupational exposures that the subjects might have experienced during their work life. Assessment was made by consensus.
Plant-specific exposures
The presence of several known carcinogens required a systematic method to assess occupational exposures. The technical documents provided by a plant engineer and validated by longterm and retired workers made this type of assessment possible. These documents set forth the association between buildings, production, industrial phases and chemicals used or synthesised.
This systematic assessment classified each job period according to the probability of exposure to each substance in three categories: no, possible or definite exposure.
Exposure to chloracetal C5
Because exposure to chloracetal C5 was the main hypothesis, it was thoroughly examined. The relative recency of chloracetal C5 made a more detailed assessment of exposure possible. This exposure began in 1979, but only in the research laboratory; industrial use of the Navas process dates back to 1981. Plant documents and the knowledge of long-term workers about work conditions in the 1980s allowed the evaluators to distinguish exposure periods in the workplace during which chloracetal C5 was handled as an intermediate substance or as a degradation product.
Exposure assessment was conducted on a case by case basis in terms of probability, intensity and frequency. Probability was defined in five categories: unexposed, or unlikely (1-20%), possible (20-50%), probable (50-80%) and definite (equal or more than 80%) exposure. Intensity was determined in three categories: low, medium and high.
Exposure frequency was the percentage of working time spent performing tasks which could have entailed exposure.
Occupational exposure assessment for nuisances not specific to the plant Exposure was assessed for selected substances, described as possible occupational risk factors for RCC: 3 4 6-11 13-16 vinyl chloride, trichloroethylene and other chlorinated solvents, petroleum or oxygenated solvents, asbestos, cadmium salts, inorganic lead compounds, welding fumes, cutting or lubricating oils, PAHs, radiation sources and plant protection products.
Statistical analysis
All analyses were performed with SAS (release V.9.1).
Cohort study
Mortality rates in the cohort were compared with the French death rates by determining standardised mortality ratios (SMRs). Each subject began contributing person-years at risk either on 1 January 1968 or 6 months after the beginning of their first employment in the plant, whichever was later, until 31 December 2006 or the date of death, if earlier. Subjects lost to follow-up-that is, subjects for whom vital status could not be determined (0.2% of the total cohort)-were censored at the last known date of work at the plant. Person-years were calculated by calendar year and 5-year age groups. The exact method was used to estimate 95% CI for SMRs and Poisson distribution was assumed for observed deaths.
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Case-control study
ORs and their corresponding 95% CIs were estimated with unconditional logistic regression with adjustment for the matching variables, that is, sex and age. We considered occupational exposures preceding RCC diagnosis for the cases and before the date at which the corresponding case was diagnosed with RCC for the controls. Analyses were conducted separately for each occupational exposure. A trend test was performed for the categorical variables.
The following exposure variables were examined for chloracetal C5: highest probability and intensity, defined as each subject's highest exposure probability (intensity) for any job period during his/her work history in the plant; a cumulative exposure index (CEI), calculated as the lifetime sum of the product of job period duration multiplied by the frequency, the midpoint of the probability category, and the intensity weight (low=1, medium=2, high=6). The CEI was used as a categorical variable as follows: not exposed=0, low=<median, medium=me-dian to <75th percentile, high=≥75th percentile.
Of the nearly 600 substances used in the plant, 24 were selected for analysis: ▸ 17 chemicals listed by the International Agency for Research on Cancer (IARC) in its groups 1 (carcinogenic to humans), 2A (probably carcinogenic to humans) and 2B ( possibly carcinogenic to humans): benzene, vinyl chloride, formaldehyde, 1,3 butadiene, dimethyl sulfate, epichlorohydrin, styrene oxide, benzyl chloride, benzoyl chloride, acrylonitrile, 1,2-dichloroethane, acetaldehyde, chloroform, dichloromethane, nickel, styrene and thiourea; ▸ 2 chemicals classified in group 3 (not classifiable as to its carcinogenicity to humans) but with renal genotoxicity shown at least in one experimental study: hydroquinone and pyridine; 20 ▸ 5 substances used in the Navas production process not classified by the IARC but whose renal toxicity was unknown: bicyclohexyl, cyclohexyl orthovanadate, sodium benzene sulfinic acid, benzenesulfonyl chloride and cyclohexene. For all these substances, the highest probability was used in the analyses.
For occupational exposures not specific to the plant, the subjects were considered as ever or never exposed. Smoking, body mass index (BMI), and hypertension, the main known risk factors for RCC, were included in the analyses as confounding factors. The screening programme by annual abdominal ultrasonography also had to be considered in the analysis. Further analyses thus adjusted for the potential screening effect. Screening was defined by at least one abdominal ultrasonography undergone before the diagnosis for the cases and before the date of the matching case's RCC diagnosis for the controls. We searched the medical data from the occupational health department for the ultrasound dates.
RESULTS
Cohort study
The total cohort comprised 2522 subjects. The median age at entry into the cohort was 26 years. Half the members entered the cohort before 1973. The mean length of employment was 16 years. A total of 2506 subjects contributed to person-years during the study period (61375 person-years for men and 19448 for women).
In all, 559 deaths were observed (474 men and 85 women), with the underlying cause of death known for 99% of the deceased (468 men and 84 women). Among men, the SMR from all causes was 0.95 (0.87 to 1.04) and the SMR from kidney cancer 1.10 (0.30 to 2.82). Among women, the SMR from all causes was 0.89 (0.71 to 1.10), and three deaths from kidney cancer were observed compared with 0.6 expected for an SMR of 5.31 (1.09 to 15.51) (table 2). No excess mortality was observed for other categories of cancer in both sexes. Since chloracetal C5 began to be synthesised in the early 1980s and this substance was the main hypothesis, further SMR analyses were conducted distinguishing two periods, before and after 1980. Any excess mortality from cancers was observed for the period 1980-2006 (data not shown).
Case-control study
The study included 18 cases (16 men and 2 women) and 82 controls (76 men and 6 women). Among the potential controls, we had encountered 29 refusals and failed to reach 16 others. This led to a response rate of 65%. At the time of the interview, five cases (18%) and eight controls (10%) were deceased for whom proxy interviews were conducted. The mean age of cases was 56 years and for controls, 55 years. Of 18 cases, 14 were clear-cell carcinomas and three papillary carcinomas. Table 3 presents the associations between RCC and the selected risk Exp, expected number of death with reference to the mortality of French population; Obs, observed number of deaths; SMR, standardised mortality ratio.
factors. BMI was associated with increased risk of RCC with a significant trend. Hypertension was also significantly related to RCC. Former and current smokers had a higher OR than neversmokers, but not significantly so. No other medical history item was significantly associated with RCC. Table 3 also shows the statistically significant association we observed between abdominal ultrasound screening and RCC. The subjects who had undergone at least one screening had a risk of RCC at least five times higher than those who had not, and those ever exposed to chloracetal C5 a risk four times higher than those never exposed (table 4) .
Before adjustment, all variables for chloracetal C5 exposure were significantly related to RCC; in particular, a statistically significant trend was shown with increasing CEI. After adjustment for screening, however, the ORs were no longer statistically significant, although the OR for the highest category of CEI remained high after adjustment (OR=4.7, 95% CI 0.8 to 29.8). The five cases whose maximal level of exposure was considered high had begun working in the plant before 1984. Apart from exposure to chloracetal C5, the ORs for definite exposure to dichloromethane, bicyclohexyl and sodium benzene sulfinic acid were significant before but not after adjustment for screening (data not shown). Substances known to be potential risk factors for RCC but not specific to the plant were not significantly associated with RCC in this study (data not shown).
DISCUSSION
To our knowledge, this study is the first investigation of a cluster of RCC cases in a plant producing vitamin A and vitamin E.
Little is known about the causes of RCC. Cigarette smoking, obesity and hypertension are the most commonly reported individual risk factors. 2 21 22 Cohort study
The mortality study allowed us to assess the general health status in this cohort, based on the all-cause mortality rate, and to determine whether any excess risk of cancer death was present. Vital status was obtained for all but five cohort members (0.2%). Underlying causes of death were available for 99% of the deceased subjects. Thus, the mortality study was very close to exhaustive.
No overall excess risk for all causes of death was observed compared with the mortality rates of the French population. The healthy worker effect was not substantial, especially among men (SMR of 0.95 for all causes of death), probably because of the long duration of the follow-up in this cohort study. Among men, no excess risk of death was observed either for all cancers or for kidney cancer. By contrast, women had a significant excess mortality from kidney cancer. However, this result was based on only three observed deaths for 0.6 expected and the CI of the relative risk was wide. These women's job histories in the plant showed no link to any chemical exposure, in particular, to chloracetal C5. The three women neither shared the same work area nor executed similar tasks. Therefore, no occupational aetiology hypothesis could be drawn from their work life. But the observation of this significant risk indicates the necessity of a longer follow-up to confirm this result.
Case-control study Abdominal ultrasound screening
Study of the relation between RCC and occupational exposure to chloracetal C5 requires that participation in the abdominal ultrasound screening programme be taken into account adequately. Screening can cause overdiagnosis by detecting nonprogressive or very slow growing cancers, 17 and it can occur in kidney cancer. 17 23 Thus, the number of RCC cases found in the study period might well have been increased by early diagnosis after screening and thus contributed to the elevated SIR observed in the preliminary phase of this study. Since screening was offered preferentially to workers exposed to chloracetal C5, a significant association between RCC and chloracetal C5 or other substances present in the same industrial phases could be explained at least in part by the existence of screening.
The role of screening history as a nuisance variable in aetiological studies of cancer has been addressed in the literature. 24 25 Several ways of dealing with screening have been suggested: adjusting for it in multivariate or stratified analysis or conducting analyses restricted to a subset of the study population in which there is little or no bias in the estimates of exposure effects. Because of the small number of cases, we chose to adjust for screening in multivariate models. 24 However, because screening was related to chloracetal C5, overadjustment might have resulted.
We then examined the ORs with and without adjustment, assuming that the real OR should lie between these two values. Screening was defined by a history for case patients of at least one screening test at any time before diagnosis. Ideally, we should have taken into account only those screening tests which took place while the disease was in a preclinical stage. 24 Unfortunately, however, the duration of this silent phase is not accurately known for RCC. Nonetheless Fenton and Weiss 26 analysed data from several studies and estimated its duration to be between 2.5 and 7.7 years among middle-aged Americans. We then conducted supplementary analyses that considered screening tests done within 2, 5 or 8 years before diagnosis. However, once workers were enrolled in the screening programme, they were likely to undergo abdominal ultrasound annually, so that the results changed only slightly.
We also conducted some additional analyses according to screening status. Despite the small number of subjects (10 cases and 19 controls with screening, eight cases and 63 controls without screening), elevated ORs, although not significant, were observed among those exposed to chloracetal C5 whatever the screening status (OR for the highest category of the CEI 4.9 (95% CI 0.5 to 51.0) among the screened and 6.1 (95% CI 0.3 to 132.1) among the not screened).
Selection of the subjects
The eight additional cases included with the 10 index cases were found either by an active search in the region or self-report to the company's occupational health department. In the absence of a cancer registry in Auvergne, the active search was conducted in collaboration with a network of pathologists and of the main hospitals in the region that treat kidney cancer. This search was limited to the Auvergne region. Therefore, a subject who left the region and was subsequently diagnosed and treated elsewhere would not have been found by this active search.
Since this was a nested case-control study, the study base of the controls was the same as that of the RCC cases. However, refusals and the impossibility of contacting the initially selected controls could have produced selection bias. Before we completed interviews with 82 controls, we had encountered 29 refusals and failed to reach 16 others. According to data collected for the cohort study, the 82 participating controls were more frequently men, were younger, and had worked in production activities and undergone screening more frequently than the 45 potential controls who did not participate.
Validity of exposure assessment
The validity of exposure assessment carried out here depends on the accuracy of both the job histories reported in the questionnaire, in particular, the job descriptions and of the plant technical document that related buildings, industrial phases and chemicals.
All exposure assessment procedures were performed blinded to case-control status. It is nonetheless possible that the cases, particularly the 10 index cases, provided more detailed information about the tasks that they were used to executing. So, a recall bias could not be excluded. Nevertheless the suspicion attached to chloracetal C5 was widely known throughout the plant, and we can suppose that description of the tasks likely to entail chemical exposures executed by the controls was as accurate as that given by the cases.
The quality of the technical document provided by the plant was independent of the disease status of the subjects. The engineer who drafted the document reviewed it with long-term and former workers to validate it. Therefore, this document should be considered complete and accurate, at least for production sectors. It could be less precise for substances handled in other workplaces.
Assessment of chloracetal C5 exposure
The plant began production of vitamin A using the Navas procedure in the early 1980s. Chloracetal C5 was synthesised and used in only two buildings during this industrial production, and direct exposure to it was easily identified. Indirect exposure concerned all workers who had worked on other phases in the same two buildings. We also tried to determine exposure to chloracetal C5 residues. The plant technical document facilitated localisation of exposure. The subjects' statements about exposure to chloracetal C5 were cross-checked by the evaluators with the plant documents and the questionnaire answers. Assessment of exposure to other substances specific to the plant
The ORs for RCC of some substances used in the Navas procedure were elevated before adjustment for screening. It should be noted that it was impossible to distinguish between exposure to chloracetal C5 and that of the products used or synthesised in the same industrial phase.
Assessment of exposures not specific to the plant
No relation was observed with potential occupational risk factors for RCC, in particular trichloroethylene or cadmium compounds. However, the small number of subjects included in the study likely means that our statistical power to analyse the relation between those factors and RCC is weak.
Relation between chloracetal C5 and RCC
The nested case-control study showed a significant doseresponse relation between RCC and cumulative exposure to chloracetal C5 before adjustment for screening. After adjustment, it was no longer statistically significant, but overadjustment is likely to have occurred. The small number of subjects has certainly resulted in weak statistical power for this analysis as well. Nonetheless, although not significant, the OR related to the highest CEI category remained high after adjustment. With regard to the metabolic pathway of chloracetal C5, this substance first seems to share structural similarity with allyl chloride. Moreover, although no toxicokinetic study is available, some hypotheses on pathways leading to compounds such as epoxide or aldehyde have been put forward. These metabolites would share the chemical structure of known mutagenic or carcinogenic substances (eg, epoxypropanal, epichlorhydrin) (personal communication: source Dr André Picot).
While the epidemiological investigations were being conducted, the plant commissioned experimental genotoxicity GLP tests for chloracetal C5. An in vivo Comet assay was carried out in Sprague-Dawley male rats by subcutaneous administration, that is, the route of administration leading to the greatest internal exposure. In this study, chloracetal C5 showed a clear genotoxic activity in the kidneys but none in the liver ( personal communication: author Dr Fabrice Nesslany, source 'Étude de la spécificité du test des comètes in vivo : application à l'étude de produits à tropisme rénal ', 2007) .
The observation of a dose-response relation and the in vivo genotoxicity are elements that support the hypothesis of a causal relation between chloracetal C5 and RCC. However, in the absence of studies in other populations, no firm conclusion can be drawn; chloracetal C5 is specific to the Navas procedure used in this plant and, to our knowledge, is not found elsewhere. Accordingly, no supplementary epidemiological investigations can be conducted.
CONCLUSIONS
Determining the cause of a case cluster in an occupational setting is known to be difficult. Several aspects of the situation studied here indicated the likelihood that an epidemiological investigation could succeed 27 : the large number of RCC cases initially reported in current or former employees of a single plant, the observation of a statistically significantly elevated SIR, a cluster made up of a single type of pathology, the availability of subjects' work histories, the in vitro genotoxicity of the suspected agent, chloracetal C5, first observed in the early 1990s, and excellent cooperation by the plant management and employees.
Nonetheless, the case-control study did not allow us to reach a definitive conclusion that chloracetal C5 is causally associated with RCC. In addition, our investigation required several steps that turned out to be much more time consuming than expected: need for data entry to set up the cohort; identification and localisation of the subjects who were to be included in the case-control study; and occupational exposure assessment by expert industrial hygienists. Therefore, it took 7 years to complete the investigation. This time would have been substantially shorter had the employees' identification data and work histories been kept in computerised files. This is a first recommendation that we suggest to facilitate the performance of future cluster investigations and epidemiological surveillance in specific companies when needed.
Although our results do not firmly confirm the causal role of chloracetal C5, the observation of a dose-response relation and the finding of in vivo genotoxic activity constitute strong arguments which support this hypothesis. We recommend that the plant continue to improve working conditions so that no employee is exposed to chloracetal C5 in normal or accidental situations. At the end of the investigation, it was suggested that the European regulation on the classification, labelling and packaging of substances and mixtures (CLP) be applied to chloracetal C5. The French Agency for Food, Environmental and Occupational Health and Safety (ANSES) considered this question, and its experts concluded that CLP regulations are not applicable to chloracetal C5 because of its non-isolated intermediate status (CLP Regulation (EC) No 1272/2008). In addition, the Ministries of Labour and Health have concluded that the medical surveillance of the plant employees should be more precisely standardised. They have asked the French National Authority for Health (HAS) to develop guidelines for such medical surveillance.
It will not be easy to identify all future RCC cases in the current and former plant employees, as employees may leave the plant or move. Nonetheless, since 2008, other RCC cases among past and present plant employees have been reported to the plant occupational physician and to the 'Association des victimes de la chimie'. The French Institute for Public Health Surveillance recommends that a long-term follow-up of, at a minimum, mortality be organised, to look for a future excess of kidney cancer mortality.
